|
 
New Lower Price and Free Training Devices for Medas Market Leader EPIPEN® Auto-Injector

New Lower Price and Free Training Devices for Medas Market Leader EPIPEN® Auto-Injector

MEDA Pharmaceuticals is reducing the price of its EpiPen® Auto-Injector by 8.1% to £26.45 and launching free training devices to help patients use the devices properly.

EpiPen® Auto-Injector is the market leader for the emergency treatment of severe allergic reactions (anaphylaxis) in children and adults. The potentially life-saving treatment is relied on by thousands of people in the UK at risk of an allergic emergency.

Meda Pharmaceuticals recently signed a long-term agreement with Mylan Incs Dey Pharma, L.P. for the exclusive marketing and distribution rights for EpiPen® Auto-Injector. This came into effect at the start of April.

David Bennett, General Manager, Meda UK said: We are working very closely with the manufacturer to deliver a robust and consistent supply of EpiPen® Auto-Injector which will continue to be available through Alliance Healthcare.

Meda has long-standing expertise in allergy medicine throughout the world and we are keen to provide support to the prescriber, caregiver and patient alike.

Meda will also be providing free training devices for patients so they can practise using an EpiPen® Auto-Injector without its needle to improve their technique. Patients will also be able to register online with Medas expiry alert service to ensure their devices are within their expiry date. And from this month, patients can order free protective hard carry cases for their EpiPen® Auto-Injector. All these can be requested from the new website www.epipen.co.uk.

EpiPen® Auto-Injectors have been designed for use under stressful conditions by patients and caregivers, often without the assistance of a healthcare professional. There are two products in the range: EpiPen and EpiPen Jr adrenaline (epinephrine).

For more information visit www.epipen.co.uk or www.meda.se or contact Meda customer service line on 0845 460 0000.

 
 
About The Operating Theatre Journal

The Operating Theatre Journal, OTJ, is published monthly and distributed to every hospital operating theatre department in the UK. The distribution includes both the National Health Service and the Private Sector.

More »
Follow & Share

Follow The Operating Theatre Journal on Facebook Follow The Operating Theatre Journal on Twitter Follow The Operating Theatre Journal on LinkedIn Follow The Operating Theatre Journal RSS Feed

Help & Support

Problems with, or comments about, this website may be emailed to:
webmaster@lawrand.com

Get in touch

Telephone: +44 (0)2921 680068
Skype: Lawrand Ltd
Email: admin@lawrand.com